ibandronic acid has been researched along with Osteosarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, C; Karlic, H; Klaushofer, K; Spitzer, S; Thaler, R; Varga, F | 1 |
| Adwan, H; Bäuerle, T; Berger, MR; Elazer, V; Golomb, G; Najajreh, Y | 1 |
| Bauss, F; Ghilardi, JR; Halvorson, KG; Koewler, NJ; Mantyh, PW; Sevcik, MA; Sullivan, LJ | 1 |
3 other study(ies) available for ibandronic acid and Osteosarcoma
| Article | Year |
|---|---|
Ibandronate increases the expression of the pro-apoptotic gene FAS by epigenetic mechanisms in tumor cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Density Conservation Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Diphosphonates; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Down-Regulation; Epigenesis, Genetic; fas Receptor; Female; Gene Silencing; Humans; Ibandronic Acid; Male; Mice; Neoplasm Proteins; Osteosarcoma; Promoter Regions, Genetic; Up-Regulation | 2013 |
Decreased levels of osteopontin and bone sialoprotein II are correlated with reduced proliferation, colony formation, and migration of GFP-MDA-MB-231 cells.
Topics: Adult; Bone Neoplasms; Breast Neoplasms; Cell Division; Cell Movement; Child; Colony-Forming Units Assay; Diphosphonates; Down-Regulation; Female; Green Fluorescent Proteins; Humans; Ibandronic Acid; Immunoglobulin G; Integrin-Binding Sialoprotein; Luminescent Proteins; Male; Oligonucleotides, Antisense; Organophosphates; Osteoblasts; Osteopontin; Osteosarcoma; Quaternary Ammonium Compounds; Sialoglycoproteins | 2004 |
Intravenous ibandronate rapidly reduces pain, neurochemical indices of central sensitization, tumor burden, and skeletal destruction in a mouse model of bone cancer.
Topics: Animals; Biomarkers, Tumor; Bone Density Conservation Agents; Bone Neoplasms; Cell Line, Tumor; Diphosphonates; Disease Models, Animal; Ibandronic Acid; Injections, Intravenous; Male; Mice; Mice, Inbred C3H; Osteolysis; Osteosarcoma; Pain; Pain Measurement; Treatment Outcome | 2008 |